These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21029368)

  • 1. Pre-clinical and clinical significance of heparanase in Ewing's sarcoma.
    Shafat I; Ben-Arush MW; Issakov J; Meller I; Naroditsky I; Tortoreto M; Cassinelli G; Lanzi C; Pisano C; Ilan N; Vlodavsky I; Zunino F
    J Cell Mol Med; 2011 Sep; 15(9):1857-64. PubMed ID: 21029368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.
    Cassinelli G; Lanzi C; Tortoreto M; Cominetti D; Petrangolini G; Favini E; Zaffaroni N; Pisano C; Penco S; Vlodavsky I; Zunino F
    Biochem Pharmacol; 2013 May; 85(10):1424-32. PubMed ID: 23466421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
    Cassinelli G; Favini E; Dal Bo L; Tortoreto M; De Maglie M; Dagrada G; Pilotti S; Zunino F; Zaffaroni N; Lanzi C
    Oncotarget; 2016 Jul; 7(30):47848-47863. PubMed ID: 27374103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase: A Potential Therapeutic Target in Sarcomas.
    Cassinelli G; Lanzi C
    Adv Exp Med Biol; 2020; 1221():405-431. PubMed ID: 32274719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
    Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y
    Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
    Cassinelli G; Zaffaroni N; Lanzi C
    Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
    Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
    Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
    Vlodavsky I; Ilan N; Naggi A; Casu B
    Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
    Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
    J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
    Barash U; Lapidot M; Zohar Y; Loomis C; Moreira A; Feld S; Goparaju C; Yang H; Hammond E; Zhang G; Li JP; Ilan N; Nagler A; Pass HI; Vlodavsky I
    J Natl Cancer Inst; 2018 Oct; 110(10):1102-1114. PubMed ID: 29579286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.
    Doweck I; Kaplan-Cohen V; Naroditsky I; Sabo E; Ilan N; Vlodavsky I
    Neoplasia; 2006 Dec; 8(12):1055-61. PubMed ID: 17217623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
    Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
    Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.
    Cohen-Kaplan V; Naroditsky I; Zetser A; Ilan N; Vlodavsky I; Doweck I
    Int J Cancer; 2008 Dec; 123(11):2566-73. PubMed ID: 18798279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
    Lu Q; Lu M; Li D; Zhang S
    Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.